Ovarian Cancer: Fighting Back After Recurrence | Philadelphia News

Ovarian cancer’s stealthy nature and late diagnosis make it a relentless foe, with 70% of patients facing recurrence after initial treatment. While newer therapies like PARP inhibitors and ADCs offer hope beyond chemo, the real battle is in early detection and long-term survival. Supportive care—acupuncture, nutrition, massage—is rising as vital for quality of life. Research pushes forward on better diagnostics and treatments, fueled by families turning grief into advocacy, striving to prevent future losses and transform outcomes for all. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/3785f170017fc6cb